scispace - formally typeset
Open AccessJournal ArticleDOI

Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review

TLDR
Improving adherence in schizophrenia may have a considerable positive impact on patients and society by focusing on the identified multitude of factors driving nonadherence, including lack of insight, medication beliefs and substance abuse.
Abstract
Background:Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment.Methods:We performed a systematic review of factors that influence adherence and the consequences of nonadherence to the patient, healthcare system and society, in patients with schizophrenia. Particular attention was given to the effect of nonadherence on hospitalization rates, as a key driver of increased costs of care. A qualitative systematic literature review was conducted using a broad search strategy using disease and adherence terms. Due to the large number of abstracts identified, article selection was based on studies with larger sample sizes published after 2001. Thirty-seven full papers were included: 15 studies on drivers and 22 on consequences, of which 12 assessed the link between nonadherence and hospitalization.Results:Key drivers of nonadherence included lack of insight, medication beliefs and substance abuse. Key consequences of nonadherence included greater risk of relapse,...

read more

Citations
More filters
Journal ArticleDOI

Insight and suicidality in psychosis: A cross-sectional study

TL;DR: Suicidality in psychosis was linked with some insight dimensions: awareness of mental illness and awareness of social consequences, but not compliance.
Journal ArticleDOI

Long‐acting antipsychotic medication as first‐line treatment of first‐episode psychosis with comorbid substance use disorder

TL;DR: Current literature on long‐acting injectable antipsychotics (LAI‐AP) use in FEP is scarce and studies often exclude patients with SUD, so patients may be excluded from studies.
Journal ArticleDOI

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis.

TL;DR: It is demonstrated usage of DPC hospital data in schizophrenia pharmacotherapy based on classification of co-diagnoses can provide an opportunity for reduced re-hospitalization and ER visit rates among patients with schizophrenia.
Journal ArticleDOI

Comparisons between suicide in persons with serious mental illness, other mental disorders, or no known mental illness: Results from 37 U.S. states, 2003-2017.

TL;DR: In this paper, the authors performed a retrospective analysis of suicide deaths in individuals aged ≥18 years from the National Violent Death Reporting System, 2003-2017 and found that persons with schizophrenia and other serious mental illnesses are overrepresented in suicide deaths.
Journal ArticleDOI

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data.

TL;DR: The notion that good adherence to antipsychotic medication reduces the risk of rehospitalization of schizophrenia patients is supported, and Appropriate measures should be taken to improve adherence.
References
More filters
Journal ArticleDOI

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

TL;DR: Recommendations for addressing adherence problems to improve patient outcomes are developed, noting that multiple problems may be involved, requiring a combination of interventions.
Journal ArticleDOI

Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

TL;DR: This study showed a direct correlation between estimated partial compliance and hospitalization risk among patients with schizophrenia across a continuum of compliance behavior.
Related Papers (5)

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.